These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Cost-effectiveness of drotrecogin alfa (activated) in the treatment of severe sepsis with multiple organ failure. Riou França L; Launois R; Le Lay K; Aegerter P; Bouhassira M; Meshaka P; Guidet B Int J Technol Assess Health Care; 2006; 22(1):101-8. PubMed ID: 16673686 [TBL] [Abstract][Full Text] [Related]
25. Drotrecogin alfa (activated) for the treatment of severe sepsis and septic shock. Rice TW; Bernard GR Am J Med Sci; 2004 Oct; 328(4):205-14. PubMed ID: 15486535 [TBL] [Abstract][Full Text] [Related]
26. Estimate of the number of patients eligible for treatment with drotrecogin alfa (activated) based on differing international indications: post-hoc analysis of an inception cohort study in Australia and New Zealand. Finfer S; Felton T; Blundell A; Lipman J; Anaesth Intensive Care; 2006 Apr; 34(2):184-90. PubMed ID: 16617638 [TBL] [Abstract][Full Text] [Related]
27. Drotrecogin alfa (activated): does current evidence support treatment for any patients with severe sepsis? Friedrich JO; Adhikari NK; Meade MO Crit Care; 2006; 10(3):145. PubMed ID: 16762040 [TBL] [Abstract][Full Text] [Related]
28. Clinical response to unintentionally rapid infusion of drotrecogin alfa (activated). Urban TM; Mitchell GA; Wellborn-Kim JJ; Terneus WF; Callahan CM; Mendes J; Webber SL Am J Health Syst Pharm; 2010 Jul; 67(14):1174-7. PubMed ID: 20592322 [TBL] [Abstract][Full Text] [Related]
29. Conclusions: drotrecogin alfa (activated)--from bench to practical use at the bedside. Maki DG Am J Surg; 2002 Dec; 184(6A Suppl):S47-50. PubMed ID: 12521617 [No Abstract] [Full Text] [Related]
30. An economic evaluation of activated protein C treatment for severe sepsis. Manns BJ; Lee H; Doig CJ; Johnson D; Donaldson C N Engl J Med; 2002 Sep; 347(13):993-1000. PubMed ID: 12324556 [TBL] [Abstract][Full Text] [Related]
31. Evaluation of the cost-effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom. Green C; Dinnes J; Takeda AL; Cuthbertson BH Int J Technol Assess Health Care; 2006; 22(1):90-100. PubMed ID: 16673685 [TBL] [Abstract][Full Text] [Related]
32. Drotrecogin alfa (activated) for severe sepsis. Drug Ther Bull; 2006 Jan; 44(1):5-8. PubMed ID: 16425899 [TBL] [Abstract][Full Text] [Related]
33. International integrated database for the evaluation of severe sepsis and drotrecogin alfa (activated) therapy: analysis of efficacy and safety data in a large surgical cohort. Payen D; Sablotzki A; Barie PS; Ramsay G; Lowry S; Williams M; Sarwat S; Northrup J; Toland P; McL Booth FV Surgery; 2006 Nov; 140(5):726-39. PubMed ID: 17084715 [TBL] [Abstract][Full Text] [Related]
34. Recombinant human activated protein C, drotrecogin alfa (activated): a novel therapy for severe sepsis. Kanji S; Devlin JW; Piekos KA; Racine E Pharmacotherapy; 2001 Nov; 21(11):1389-402. PubMed ID: 11714212 [TBL] [Abstract][Full Text] [Related]
35. Management of patients with severe sepsis, treated by drotrecogin alfa (activated). Laterre PF; Heiselman D Am J Surg; 2002 Dec; 184(6A Suppl):S39-46. PubMed ID: 12521616 [TBL] [Abstract][Full Text] [Related]
36. Drotrecogin alfa (recombinant human activated protein C) in severe acute pancreatitis. Jamdar S; Siriwardena AK Crit Care; 2005 Aug; 9(4):321-2. PubMed ID: 16137370 [TBL] [Abstract][Full Text] [Related]
37. Introduction: rationale for using drotrecogin alfa (activated) in patients with severe sepsis. Dhainaut JF Am J Surg; 2002 Dec; 184(6A Suppl):S5-10. PubMed ID: 12521612 [No Abstract] [Full Text] [Related]
38. Timing of drotrecogin alfa (activated) initiation in treatment of severe sepsis: a database cohort study of hospital mortality, length of stay, and costs. Ernst FR; Johnston JA; Pulgar S; He J; Ball DE; Young JK; Cooper LM Curr Med Res Opin; 2007 Jan; 23(1):235-44. PubMed ID: 17207305 [TBL] [Abstract][Full Text] [Related]
39. The use of drotrecogin alfa (activated) in severe sepsis during acute pancreatitis - two case studies. Machała W; Wachowicz N; Komorowska A; Gaszyński W Med Sci Monit; 2004 Jul; 10(7):CS31-6. PubMed ID: 15232511 [TBL] [Abstract][Full Text] [Related]